Utah Medical Products, Inc. (UTMD)

Utah Medical Products Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	16.38	16.64	16.47	14.79	10.8	14.73
Depreciation & Amortization	5.29	6.37	7.08	7.28	7.21	6.88
Share-Based Compensation	0.27	0.24	0.19	0.21	0.17	0.14
Other Operating Activities	-1.3	-0.96	-2.6	-1.07	1.96	-4.69
Operating Cash Flow	20.64	22.28	21.15	21.2	20.14	17.06
Operating Cash Flow Growth	-10.31%	5.36%	-0.26%	5.29%	18.06%	1.32%
Capital Expenditures	-0.59	-0.64	-0.81	-0.55	-0.86	-0.54
Other Investing Activities	-	-	-0.01	-	-	-21
Investing Cash Flow	-0.59	-0.64	-0.82	-0.55	-0.86	-21.54
Dividends Paid	-4.3	-4.28	-3.16	-11.47	-4.12	-4.11
Share Issuance / Repurchase	-2.8	0.12	-2.32	0.56	-6.62	-0.12
Financing Cash Flow	-7.1	-4.17	-5.48	-10.91	-10.73	-4.23
Exchange Rate Effect	-0.06	0.34	-0.77	-0.36	0.26	0.39
Net Cash Flow	12.9	17.82	14.08	9.38	8.8	-8.33
Free Cash Flow	20.05	21.64	20.34	20.65	19.28	16.52
Free Cash Flow Growth	-10.49%	6.41%	-1.52%	7.13%	16.72%	-4.50%
Free Cash Flow Margin	40.88%	43.09%	38.90%	42.10%	45.70%	35.21%
Free Cash Flow Per Share	5.54	5.96	5.61	5.66	5.29	4.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).